Crossmark

Results of the REVEAL study. Why should we not welcome a new lipid-lowering agent?

Crossref DOI link: https://doi.org/10.1016/j.artere.2017.11.003

Published Print: 2017-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Masana, Luis
License Information

Text and Data Mining valid from 2017-11-01
More Information

This article is maintained by: Elsevier

Article Title: Results of the REVEAL study. Why should we not welcome a new lipid-lowering agent?

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2017.11.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2017.10.002

Content Type: article

Copyright: © 2017 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.